1989
DOI: 10.1016/0304-3835(89)90209-7
|View full text |Cite
|
Sign up to set email alerts
|

Urinary and faecal excretion of pyrene and hydroxypyrene by rats after oral, intraperitoneal, intratracheal or intrapulmonary application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
0

Year Published

1994
1994
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(17 citation statements)
references
References 15 publications
1
16
0
Order By: Relevance
“…It is not uncommon for any orally ingested chemical compound, that the unmetabolized component is transported into the lumen of the GI tract and eliminated through feces. Similar to the present study, several other studies have reported unchanged PAHs such as BaP [17], chrysene [18] and pyrene [19] in rats orally exposed to these chemicals. The differences in the levels of unchanged FLA among the vehicles noticed in the present study suggests that the presence of unchanged FLA depend on the bioavailability of the administered dose and lipid content in the vehicle.…”
Section: Discussionsupporting
confidence: 91%
“…It is not uncommon for any orally ingested chemical compound, that the unmetabolized component is transported into the lumen of the GI tract and eliminated through feces. Similar to the present study, several other studies have reported unchanged PAHs such as BaP [17], chrysene [18] and pyrene [19] in rats orally exposed to these chemicals. The differences in the levels of unchanged FLA among the vehicles noticed in the present study suggests that the presence of unchanged FLA depend on the bioavailability of the administered dose and lipid content in the vehicle.…”
Section: Discussionsupporting
confidence: 91%
“…If there are no significant differences between the two routes of administration, an oral dose will be used, because it is simpler and more practical. Several previous studies have examined the bioavailability and urinary excretion of BaP and pyrene metabolites after oral, intravenous, cutaneous, intraperitoneal, or intrapulmonary administration to rats (Jacob et al, 1989;Van de Wiel et al, 1993;Bouchard and Viau, 1997). They found that the formation of metabolites varied greatly after different administration routes.…”
Section: Discussionmentioning
confidence: 99%
“…The extensive formation of DNA adducts in lung, an organ distant from the site of exposure, indicates that lung is particularly susceptible to genotoxicity induced by chemical components of complex mixtures. Studies have also demonstrated the usefulness of 1-hydroxypyrene excretion in urine as a biological marker of exposure to PAHs (Jongeneelen et al, 1985(Jongeneelen et al, , 1986Jacob et al, 1989). Clonfero and co-workers (1990) recently determined that urinary 1-hydroxypyrene levels correlated in humans treated with pharmaceutical coal tar.…”
Section: Discussionmentioning
confidence: 96%